News

In recognition of global Geographic Atrophy Week, Prevent Blindness is providing free educational resources on GA for patients, care partners and healthcare professionals

At this year’s EURETINA meeting, retina specialists highlighted important developments in diabetic macular oedema and diabetic retinopathy research

Data show transfection in both eyes despite unilateral injection

In early November, the EU MDR issued a CE mark certification for RetInSight’s AI-based geographic atrophy monitor

The carbomer-containing eye gels carry risk of microbial contamination, the regulatory agency warned

Moving toward eliminating drug and chemical safety testing in animals

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Rob Thornhill, CEO of Centricity Vision, spoke with the Ophthalmology Times team about developments in the company's ZEPTOLink IOL positioning systems.

Patients who received digital education demonstrated a better understanding of their disease and its management

Dr Marco Zarbin emphasises the importance of defining “active disease”

In the clinical trial, Oxurion’s novel PKal Inhibitor, THR-149, did not meet its primary endpoint

Infrastructure across Europe needs a major overhaul to optimise education and patient access in groundbreaking treatments

A patient filed a complaint in June 2019 claiming their medical records had been accessed by an NHS employee

Larger 0.6-mm temporary plug features a tapered edge

Developing technology may offer marked improvements in surgical precision

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Penny Asbell, MD, FACS, presented results from the ARMOR Study

The company received marketing authorisation approval in the EU earlier this year

The endorsement follows FDA approval in the United States this summer

At this year's American Academy of Ophthalmology meeting, the Ophthalmology Times team spoke with Megan Baldwin, MD, founder of Opthea Limited, about the company's ShORe and COAST clinical trials

At AAO 2023, Rich Small, CEO of Neurotech, spoke with our team about the company's development of encapsulated cell therapy, NT-501

In this case study, a patient with recently diagnosed cancer demonstrated significant improvement for ocular symptoms of BDUMP following plasmapheresis

At the 2023 AAO meeting, Paul Runge, MD, FACS, spoke with Ophthalmology Times about his time in Ukraine treating retinopathy of prematurity (ROP) and implementing the Norlase Lion laser at this year's American Academy of Ophthalmology meeting.

At this year's American Academy of Ophthalmology meeting, Anthony Wallace, BS, MBA, vice president and general manager of the surgical business at Bausch + Lomb North America, spoke with us about three exciting new launches

A study demonstrates corneal endothelial cell density measured postoperatively does not differ whether the capsulotomy was performed using continuous curvilinear capsulorhexis (CCC) or precision pulse capsulotomy (PPC)

Ben Bergo, CEO of Visus Therapeutics, spoke with Ophthalmology Times about the BRIO-I study on presbyopia

Researchers from Anglia Ruskin University and the University of Oxford conducted a study that reveals knowledge gaps for conditions that affect 18-64-year-olds in the UK

Analysis of data from the European Union and the United States showed low-dose, preservative-free formulation of atropine is effective in slowing myopia progression in children